Sign on
Join us in urging the World Health Organization to consolidate its guidance regarding the treatment for multidrug-resistant tuberculosis (MDR-TB), and in the interim, as a matter of urgency, to recommend bedaquiline as part of the preferred regimen for patients with MDR-TB in place of the injectable agent.
Email address *
How would you like to sign on? *
Never submit passwords through Google Forms.
This form was created inside of Treatment Action Group. Report Abuse - Terms of Service - Additional Terms